April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...

The effectiveness of inhaled glucocorticoids in shortening the time to symptom resolution or preventing hospitalization or death among outpatients with mild-to-moderate coronavirus disease 2019 (Covid ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Enerzair Breezhaler, the first triple-combination asthma therapy that ...

The 110mcg strength of Asmanex Twisthaler (mometasone furoate inhalation powder, from Schering-Plough), an inhaled corticosteroid, is now available for the maintenance treatment of asthma in patients ...

According to a recent study presented at the American Thoracic Society International Conference in Dallas, Texas, and simultaneously published in the New England Journal of Medicine, nearly ...

Usage: Ipratropium is often used in combination with albuterol for acute asthma exacerbations in emergency settings.